Raymond James & Associates Zynex Inc Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$10.35 - $15.65 $221,614 - $335,097	-21,412 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$12.25 - $14.87 $397,708 - $482,769	-32,466 Reduced 60.26%	21,412 $333,000
Q1 2021 May 14, 2021	SELL	$12.28 - $19.74 $60,761 - $97,673	-4,948 Reduced 8.41%	53,878 $823,000
Q4 2020 Feb 12, 2021	BUY	$11.65 - $17.94 $36,674 - $56,475	3,148 Added 5.65%	58,826 $792,000
Q3 2020 Nov 04, 2020	BUY	$12.98 - $25.98 $722,700 - $1.45 Million	55,678 New	55,678 $972,000

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $293M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.